Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Severine Vermeire

Showing results (31-40 of 232) with videos related to

Pageof 24
Sort By:
United European Gastroenterology Journal|July 19, 2019
Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseasesClaire Liefferinckx, Bram Verstockt, Ann Gils, et al.
Clinical Chemistry|September 25, 2004
Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac diseaseBritta Van Meensel, Martin Hiele, Ilse Hoffman, et al.
Romanian Journal of Gastroenterology|April 1, 2005
Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in RomaniaCarmen Monica Preda, Mircea Diculescu, Virginia Mirea, et al.
International Journal of Colorectal Disease|January 22, 2021
Positioning strictureplasty in the treatment of extensive Crohn's disease ileitis: a comparative study with ileocecal resectionGabriele Bislenghi, Steffen Fieuws, Albert Wolthuis, et al.
Clinical and Translational Gastroenterology|January 11, 2013
Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trialVicky De Preter, Marie Joossens, Vera Ballet, et al.
Current Microbiology|February 28, 2008
Coamplification of eukaryotic DNA with 16S rRNA gene-based PCR primers: possible consequences for population fingerprinting of complex microbial communitiesGeert Huys, Tom Vanhoutte, Marie Joossens, et al.
Inflammatory Bowel Diseases|May 21, 2005
Crohn's disease and month of birthMarc Van Ranst, Marie Joossens, Sofie Joossens, et al.
Inflammatory Bowel Diseases|December 24, 2005
Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseasesMarie Pierik, Sofie Joossens, Kristel Van Steen, et al.
The New England Journal of Medicine|February 14, 2003
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's diseaseFilip Baert, Maja Noman, Severine Vermeire, et al.
Microbes and Infection|January 2, 2007
Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal diseaseLeen Moens, Jan Verhaegen, Marie Pierik, et al.
Pageof 24

Showing results (31-40 of 232) with videos related to

Sort By:
Pageof 24
United European Gastroenterology Journal|July 19, 2019
Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseasesClaire Liefferinckx, Bram Verstockt, Ann Gils, et al.
Clinical Chemistry|September 25, 2004
Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac diseaseBritta Van Meensel, Martin Hiele, Ilse Hoffman, et al.
Romanian Journal of Gastroenterology|April 1, 2005
Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in RomaniaCarmen Monica Preda, Mircea Diculescu, Virginia Mirea, et al.
International Journal of Colorectal Disease|January 22, 2021
Positioning strictureplasty in the treatment of extensive Crohn's disease ileitis: a comparative study with ileocecal resectionGabriele Bislenghi, Steffen Fieuws, Albert Wolthuis, et al.
Clinical and Translational Gastroenterology|January 11, 2013
Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trialVicky De Preter, Marie Joossens, Vera Ballet, et al.
Current Microbiology|February 28, 2008
Coamplification of eukaryotic DNA with 16S rRNA gene-based PCR primers: possible consequences for population fingerprinting of complex microbial communitiesGeert Huys, Tom Vanhoutte, Marie Joossens, et al.
Inflammatory Bowel Diseases|May 21, 2005
Crohn's disease and month of birthMarc Van Ranst, Marie Joossens, Sofie Joossens, et al.
Inflammatory Bowel Diseases|December 24, 2005
Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseasesMarie Pierik, Sofie Joossens, Kristel Van Steen, et al.
The New England Journal of Medicine|February 14, 2003
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's diseaseFilip Baert, Maja Noman, Severine Vermeire, et al.
Microbes and Infection|January 2, 2007
Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal diseaseLeen Moens, Jan Verhaegen, Marie Pierik, et al.
Pageof 24